Coronary disease & ACS

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort : A Prospective Observational Cohort Study

Ann Intern MedPublished Prospective cohort study

Authors' conclusion

In asymptomatic persons, subclinical, obstructive coronary atherosclerosis is associated with a more than 8-fold elevated risk for myocardial infarction.

Study context

Population
Asymptomatic persons aged ≥40 years without known ischemic heart disease, Copenhagen General Population Study, Denmark; assessed by coronary CT angiography
Participants
9,533 persons
Exposure
Subclinical coronary atherosclerosis vs none
  • No atherosclerosisn = 5,114reference
  • Nonobstructiven = 3,483
  • Obstructiven = 936
Outcome
Myocardial infarction
Follow-up
Median 3.5 years
Methodological detailsobservational, Coronary CT angiography conducted blinded to treatment and outcomes
  • Observational
  • Coronary CT angiography conducted blinded to treatment and outcomes

Main finding

As reported in the abstract

MI · median 3.5 years
Each group vs no atherosclerosisAdjusted relative risk (95% CI)
Obstructive
9.19(4.49–18.11)
Extensive
7.65(3.53–16.57)
Obstructive-extensive
12.48(5.50–28.12)
Obstructive-nonextensive
8.28(3.75–18.32)
Persons with MI
71

Observational data: associations, not effects.

Secondary outcomes

OutcomeAdjusted RR (CI)
Death or MI (composite)Nonobstructive-extensivevs No atherosclerosis2.70 (1.72–4.25)
Death or MI (composite)Obstructive-extensivevs No atherosclerosis3.15 (2.05–4.83)
Death or MI (composite) — Deaths
193

Death or MI (composite)

Risk increased with extensive disease regardless of degree of obstruction

Original publication

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort : A Prospective Observational Cohort Study. Ann Intern Med. Published 28 March 2023. doi:10.7326/m22-3027

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.